An intervention to improve pneumococcal vaccination uptake in high risk 50-64 year olds vs. expanded age-based recommendations: an exploratory cost-effectiveness analysis

• Главные авторы: Angela R. Wateska (Автор), Mary Patricia Nowalk (Автор), Chyongchiou J. Lin (Автор), Lee H. Harrison (Автор), William Schaffner (Автор), Richard K. Zimmerman (Автор), Kenneth J. Smith (Автор)
• Формат: ‌
• Опубликовано: Taylor & Francis Group, 2019-04-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

In the U.S., pneumococcal polysaccharide vaccine (PPSV23) uptake among high-risk adults aged <65 years is consistently low and improvement is needed. One barrier to improved vaccine coverage is the complexity of the adult vaccination schedule. This exploratory analysis compared the cost-effective...